We are live on ! Find out more
TSRX

TRIUS THERAPEUTICS INC COM STK (DE)
TSRX

Delisted

TSRX was delisted on the 11th of September, 2013.

84 hedge funds and large institutions have $145M invested in TRIUS THERAPEUTICS INC COM STK (DE) in 2013 Q2 according to their latest regulatory filings, with 84 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

79% less call options, than puts

Call options by funds: $623K | Put options by funds: $2.97M

Holders
84
Holders Change
+84
Holders Change %
% of All Funds
2.74%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
84
Increased
Reduced
Closed
Calls
$623K
Puts
$2.97M
Net Calls
-$2.34M
Net Calls Change
-$2.34M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
AllianceBernstein
51
AllianceBernstein
Tennessee
$339K +$309K +41,785 New
Citadel Advisors
52
Citadel Advisors
Florida
$315K +$287K +38,816 New
State Board of Administration of Florida Retirement System
53
State Board of Administration of Florida Retirement System
Florida
$303K +$276K +37,362 New
RhumbLine Advisers
54
RhumbLine Advisers
Massachusetts
$270K +$246K +33,291 New
Manulife (Manufacturers Life Insurance)
55
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$257K +$234K +31,705 New
BMC
56
Benin Management Corp
Connecticut
$243K +$222K +30,000 New
WB
57
WesBanco Bank
West Virginia
$243K +$222K +30,000 New
ProShare Advisors
58
ProShare Advisors
Maryland
$237K +$215K +29,142 New
MLICM
59
Metropolitan Life Insurance Company (MetLife)
New York
$236K +$215K +29,074 New
Citigroup
60
Citigroup
New York
$223K +$202K +27,414 New
LOM
61
Loeb Offshore Management
New York
$218K +$199K +26,900 New
U
62
UBS
Switzerland
$214K +$195K +26,412 New
DekaBank Deutsche Girozentrale
63
DekaBank Deutsche Girozentrale
Germany
$197K +$188K +25,500 New
AIG
64
American International Group
New York
$172K +$156K +21,180 New
PP
65
PDT Partners
New York
$153K +$139K +18,857 New
AQR Capital Management
66
AQR Capital Management
Connecticut
$141K +$129K +17,400 New
BA
67
BlackRock Advisors
Delaware
$137K +$125K +16,895 New
AL
68
Airain Ltd
Guernsey
$135K +$123K +16,606 New
FNBT
69
FineMark National Bank & Trust
Florida
$122K +$111K +15,000 New
GC
70
Guggenheim Capital
Illinois
$121K +$111K +14,993 New
Goldman Sachs
71
Goldman Sachs
New York
$120K +$110K +14,848 New
BNP Paribas Financial Markets
72
BNP Paribas Financial Markets
France
$108K +$98K +13,272 New
DTL
73
Dynamic Technology Lab
Singapore
$103K +$93.6K +12,671 New
LCS
74
Levin Capital Strategies
New York
$101K +$92.3K +12,500 New
LPL Financial
75
LPL Financial
California
$95K +$86.6K +11,720 New

TSRX Hedge Fund Activity: Q2 2013 in Review

84 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) for Q2 2013, worth a combined $145M.

Buyers outnumbered sellers: 84 funds opened new TSRX positions and 0 closed out — a net gain of 84 holders — while 0 added to existing stakes and 0 trimmed.

  • 84 institutional investors held TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $145M of TRIUS THERAPEUTICS INC COM STK (DE) stock for Q2 2013.
  • 84 funds opened new TRIUS THERAPEUTICS INC COM STK (DE) positions in Q2 2013 and 0 closed out, a net change of +84 holders.

Based on aggregated 13F filings for Q2 2013.